AKTS · Aktis Oncology, Inc.
$24.01
-0.80 (-3.22%)
At close · Jul 23
Market Cap
$1.33B
Shares
55.28M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-07-20 | KEN HERRMANN | Director | 4,856 | 2026-07-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-17 | KEN HERRMANN | Director | 3,065 | 2026-07-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-08 | AKOS CZIBERE | Officer | 50,000 | 2026-07-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-08 | SHULAMIT RON-BIGGER | Officer | 50,000 | 2026-07-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–4 of 4 filings
Key facts
CIK
2035832
CUSIP
01021M104
13F (30d)
11 filings
11 filers
Visit website
Investor relations